JPMorgan Chase Bank, National AssociationCall Option Transaction • November 8th, 2010 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between JPMorgan Chase Bank, National Association, London Branch (“Dealer”) and Gilead Sciences, Inc. (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction.
August 5, 2010Warrant Agreement • November 8th, 2010 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Gilead Sciences, Inc. (“Company”) to JPMorgan Chase Bank, National Association, London Branch (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction.
Attention: Treasurer Telephone No.: (650) 522-5727 Facsimile No.: (650) 522-3000 A/C: 028820868 Ref. No.: SDB1631893036Warrant Agreement • November 8th, 2010 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Gilead Sciences, Inc. (“Company”) to Goldman, Sachs & Co. (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction.
August 30, 2010Base Call Option Transaction • November 8th, 2010 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
Goldman, Sachs & Co.Additional Call Option Transaction • November 8th, 2010 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
August 30, 2010Base Call Option Transaction • November 8th, 2010 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
Goldman, Sachs & Co.Base Call Option Transaction • November 8th, 2010 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
Goldman, Sachs & Co.Base Call Option Transaction • November 8th, 2010 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
August 30, 2010Additional Call Option Transaction • November 8th, 2010 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
August 30, 2010Additional Call Option Transaction • November 8th, 2010 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
Goldman, Sachs & Co.Additional Call Option Transaction • November 8th, 2010 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
EXECUTION VERSIONWarrant Agreement • November 8th, 2010 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Gilead Sciences, Inc. (“Company”) to Goldman, Sachs & Co. (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements and serve as the final documentation for this Transaction.
